Celltrion's Herceptin Biosimilar One Step Closer To US FDA Approval

 
• By Jung Won Shin
  
Celltrion Headquarters
Celltrion HQ in Incheon, South Korea • Source: Celltrion Inc.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics